Evaluation of smear microscopy and geneXpert for the rapid diagnosis of pulmonary and extrapulmonary tuberculosis in a tertiary care hospital in North India: a descriptive prospective study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20181774Keywords:
GeneXpert, sensitivity, specificity, ZN stainingAbstract
Background: Tuberculosis is a global health problem associated with high morbidity and mortality. Rapid diagnosis of tuberculosis is essential for early disease management. Conventional methods like microscopy and culture are associated with low sensitivity and longer time to positivity respectively. The GeneXpert is an integrated device for the rapid detection of Mycobacterium tuberculosis and its sensitivity to rifampicin. We evaluated the performance of gene expert MTB/ RIF assay for the diagnosis of pulmonary and extrapulmonary tuberculosis.
Methods: A prospective cross sectional study was carried out in the Department of Microbiology. Samples were subjected to smear microscopy by ZN staining, culture on solid (LJ) and liquid media (BacT Alert) and GeneXpert assay.
Results: 122 pulmonary samples and 153 extrapulmonary samples collected from 275 patients were included in the study. Out of these, 48 samples were positive by both culture and Xpert assay and 2 samples were culture positive only. Out of 225 culture negative samples, 3 were positive by GeneXpert. The sensitivity for GeneXpert was much higher compared to smear micrscopy (96 Vs 46% respectively). The Xpert assay also detected 3 rifampcin resistant cases.
Conclusions: The test appeared to be as sensitive as culture for the detection of tuberculosis in smear positive, smear negative and extrapulmonary tuberculosis. We recommend the use of GeneXpert assay for the early detection of tuberculosis. We conclude that the test is simple and routine staff can perform the test with minimal training.
References
World Health Organization. Global Tuberculosis Report. Geneva, Switzerland: World Health Organization, 2017.
Sharma SK, Mohan A. Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. Ind J Med Res. 2013;137:455-93.
Hepple P, Ford N, McNerney R. Microscopy compared to culture for the diagnosis of tuberculosis in induced sputum samples: a systematic review. Int J Tuberc Lung Dis. 2012;16(5):579-88.
Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, Perkins MD, et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet. 2010;375:1920-37.
World Health Organization. Rapid implementation of the Xpert MTB/RIF diagnostic test. Technical and operational “How to” practical considerations. World Heal Organ Doc. 2011;WHO/HTM/TB:1-34.
Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, et al. Advances in tuberculosis diagnostics: The Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013;13(4):349-61.
Central TB Division. Directorate General of Health Services Ministry of Health and Family Welfare. TB India 2016. Revised National TB Control Programme. Technical and operational guidlines for tuberculosis control in India. 2016:144.
Pfyffer GE. Mycobacterium: General Characteristics, Laboratory Detection, and Staining Procedures. In Jorgerson JH and Pfaller MA as eds. Manual of clinical microbiology. 11th Edition. Washington DC: American Society of Microbiology. 2015:536-69.
9. Parsons LM, Somoskövi Á, Gutierrez C, Lee E, Paramasivan CN, Abimiku A, et al. Laboratory diagnosis of tuberculosis in resource-poor Countries: Challenges and opportunities. Clin Microbiol Rev. 2011;24(2):314–50.
Malbruny B, Le Marrec G, Courageux K, Leclercq R, Cattoir V. Rapid and efficient detection of Mycobacterium tuberculosis in respiratory and non-respiratory samples. Int J Tuberc Lung Dis. 2011;15(4):553-5.
World Health Organization. Implementing tuberculosis diagnostics: A policy framework. Geneva World Heal Organ. 2015;39. Available from:http://www.who.int/tb/publications/implementing_TB_diagnostics/en/.
Lombardi G, Di Gregori V, Girometti N, Tadolini M, Bisognin F, Dal Monte P. Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF. PLoS One. 2017;12(4):1-10.
Pinyopornpanish K, Chaiwarith R, Pantip C, Keawvichit R, Wongworapat K, Khamnoi P, et al. Comparison of Xpert MTB/RIF assay and the conventional sputum microscopy in detecting mycobacterium tuberculosis in Northern Thailand. Tuberc Res Treat. 2015;2015:571782.
Iram S, Zeenat A, Hussain S, Wasim Yusuf N, Aslam M. Rapid diagnosis of tuberculosis using Xpert MTB/RIF assay - Report from a developing country. Pakistan J Med Sci. 2014;31(1):105-10.
Steingart KR, Schiller I, Horne DJ, Pai M, Boehme CC, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane database Syst Rev. 2014;1(1).
Agrawal M, Bajaj A, Bhatia V, Dutt S. Comparative study of GeneXpert with ZN stain and culture in samples of suspected pulmonary tuberculosis. J Clin Diagnostic Res. 2016;10(5):09-12.
Boehme CC, Nabeta P, Hillemann D, Nicol MP., Shenai S., Krapp F, Allen J, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010;363:1005-15.
Somily AM, Barry MA, Habib HA, Alotaibi FE, Al-Zamil FA, Khan MA, et al. Evaluation of GeneXpert MTB/RIF for detection of Mycobacterium tuberculosis complex and RPO B gene in respiratory and non-respiratory clinical specimens at a tertiary care teaching hospital in Saudi Arabia. Saudi Med J. 2016;37(12):1395-8.
Maynard-Smith L, Larke N, Peters JA, Lawn SD. Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: A systematic review. BMC Infect Dis. 2014;14(1).
Bajrami R, Mulliqi G, Kurti A, Lila G, Raka L. Comparison of genexpert MTB/RIF and conventional methods for the diagnosis of tuberculosis in Kosovo. J Infect Dev Ctries. 2016;10(4):418-22.
